BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rotary Club Of Grand Rapids - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rotary Club Of Grand Rapids
X-ORIGINAL-URL:https://grrotary.org
X-WR-CALDESC:Events for Rotary Club Of Grand Rapids
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Detroit
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20180809T120000
DTEND;TZID=America/Detroit:20180809T131500
DTSTAMP:20180516T171838Z
CREATED:20180516T171838Z
LAST-MODIFIED:20180516T171838Z
UID:5101-1533816000-1533820500@grrotary.org
SUMMARY:8.9.18 - David G. Morgan. Ph.D.
DESCRIPTION:Topic Summary: \nRecent advances in understanding the causes of Alzheimer’s are leading scientists to recognize the disease begins 10-20 years before onset of symptoms.  Using biomarkers to determine who is at risk and mitigating those risks will prevent the disease for many. Finding effective treatment is also advancing quickly. The first person cured of Alzheimer’s will be in a clinical trial. Unfortunately\, Grand Rapids has no clinical trials for Alzheimer’s disease. A vision for how to develop a Center for Aging Brain C.A.R.E. (ABC center) can rectify this situation. \nDr. Morgan – Bio \nSince November 2017 “Dave” Morgan is Director of the Alzheimer’s Alliance and Global Impact Professor of Translational Sciences at Michigan State University. Previously he was CEO of the Byrd Alzheimer’s Institute at the University of South Florida.  The Byrd Alzheimer’s Institute combined patient and family services\, clinical research\, education outreach programs and laboratory science seeking the prevention\, treatment and cure of Alzheimer’s and related disorders. While there Dr Morgan oversaw development of Community-Based Memory Screening programs and the country’s first mobile clinical trial unit for Alzheimer’s disease.  Dr. Morgan’s research interests are Alzheimer’s disease\, aging and brain function. He is internationally recognized for his work on immunotherapy and gene therapy to treat the Alzheimer-related pathologies. \n  \nMorgan received his undergraduate and graduate degrees from Northwestern University and spent 10 years at the University of Southern California before joining the University of South Florida in 1992. He has participated in over 80 grant-years of NIH funded research and published over 200 research articles. Morgan regularly sits on grant review panels for NIH and other agencies. In addition to his research activities\, Morgan has consulted with both major pharmaceutical companies and small biotechnology\, and advised capital investment organizations regarding the most promising therapeutic approaches to curing Alzheimer’s disease. At the national level\, Morgan serves as Chairperson of the Program Committee for the world’s largest scientific meeting on Alzheimer’s disease (AAIC) and as Lead Representative of ResearchersAgainstAlzheimer’s\, a national advocacy organization.
URL:https://grrotary.org/event/8-9-18-indian-trails-camp/
LOCATION:University Club of Grand Rapids\, 111 Lyon St NW Suite 1025\, Grand Rapids\, MI\, 49503\, United States
CATEGORIES:Weekly Meeting
ATTACH;FMTTYPE=:
END:VEVENT
END:VCALENDAR